California State Teachers Retirement System (CalSTRS)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,666
Closed -$29K 3292
2023
Q1
$29K Sell
15,666
-1,156
-7% -$1.43K ﹤0.01% 2932
2022
Q4
$18.7K Buy
16,822
+190
+1% +$270 ﹤0.01% 3023
2022
Q3
$39K Sell
16,632
-1,387
-8% -$4.91K ﹤0.01% 3009
2022
Q2
$55K Buy
18,019
+3,924
+28% +$19.1K ﹤0.01% 3014
2022
Q1
$96K Sell
14,095
-3,701
-21% -$26.4K ﹤0.01% 2876
2021
Q4
$149K Hold
17,796
﹤0.01% 2886
2021
Q3
$132K Sell
17,796
-27,695
-61% -$172K ﹤0.01% 2900
2021
Q2
$309K Buy
45,491
+19,352
+74% +$161K ﹤0.01% 2890
2021
Q1
$268K Hold
26,139
﹤0.01% 2780
2020
Q4
$183K Hold
26,139
﹤0.01% 2874
2020
Q3
$213K Buy
26,139
+1,548
+6% +$9.6K ﹤0.01% 2689
2020
Q2
$170K Hold
24,591
﹤0.01% 2794
2020
Q1
$117K Buy
24,591
+14
+0.1% +$81 ﹤0.01% 2767
2019
Q4
$215K Buy
24,577
+152
+0.6% +$822 ﹤0.01% 2770
2019
Q3
$81K Hold
24,425
﹤0.01% 2960
2019
Q2
$121K Hold
24,425
﹤0.01% 2959
2019
Q1
$151K Sell
24,425
-6,894
-22% -$33.3K ﹤0.01% 2835
2018
Q4
$106K Buy
31,319
+7,190
+30% +$33.6K ﹤0.01% 2918
2018
Q3
$157K Hold
24,129
﹤0.01% 2942
2018
Q2
$185K Buy
24,129
+1,755
+8% +$25.3K ﹤0.01% 2917
2018
Q1
$500K Sell
22,374
-626
-3% -$13.9K ﹤0.01% 2364
2017
Q4
$293K Sell
23,000
-500
-2% -$7.35K ﹤0.01% 2673
2017
Q3
$366K Buy
23,500
+11,700
+99% +$165K ﹤0.01% 2580
2017
Q2
$166K Sell
11,800
-900
-7% -$19.3K ﹤0.01% 2955
2017
Q1
$279K Buy
+12,700
New +$269K ﹤0.01% 2743

Other funds holding JNCE

California State Teachers Retirement System (CalSTRS)'s JNCE Position: Q2 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 15,666 shares — an estimated $29K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in JNCE in Q1 2017 and held it in 25 quarters. The position peaked at $500K in Q1 2018. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 15,666 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $29K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2017 and held it in 25 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Jounce Therapeutics, Inc. Common Stock position peaked at $500K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.